Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


10.06.2019

1 AIDS
1 Am J Epidemiol
1 Clin Infect Dis
2 Eur J Gastroenterol Hepatol
1 Int J STD AIDS
2 J Hepatol
2 J Infect Dis
2 J Interferon Cytokine Res
2 J Med Virol
2 J Virol
8 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MBAE M, Owen L, Elisha KK, Ndhere A, et al
    Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya.
    AIDS. 2019;33:1404-1406.
    PubMed     Text format    


    Am J Epidemiol

  2. FRASER H, Vellozzi C, Hoerger TJ, Evans JL, et al
    Scaling-up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States - a Rural and Urban Comparison.
    Am J Epidemiol. 2019 May 31. pii: 5509380. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  3. LIN KY, Sun HY, Chen YH, Lo YC, et al
    Effect of a hepatitis A vaccination campaign during a hepatitis A outbreak in Taiwan, 2015-2017: a modeling study.
    Clin Infect Dis. 2019 Jun 3. pii: 5510337. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  4. YU ZJ, Zhang LL, Huang TT, Zhu JS, et al
    Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
    Eur J Gastroenterol Hepatol. 2019;31:873-877.
    PubMed     Text format     Abstract available

  5. HANAFY AS, Seleem WM, Basha MAA, Marei AM, et al
    Residual hepatitis C virus in peripheral blood mononuclear cell as a risk factor for hepatocellular carcinoma after achieving a sustained virological response: a dogma or fiction.
    Eur J Gastroenterol Hepatol. 2019 May 29. doi: 10.1097/MEG.0000000000001459.
    PubMed     Text format     Abstract available


    Int J STD AIDS

  6. MA J, Non L, Amornsawadwattana S, Olsen MA, et al
    Hepatitis C care cascade in HIV patients at an urban clinic in the early direct-acting antiviral era.
    Int J STD AIDS. 2019 Jun 3:956462419832750. doi: 10.1177/0956462419832750.
    PubMed     Text format     Abstract available


    J Hepatol

  7. GOTLIEB N, Moradpour D, Shouval D
    Hepatitis A and E - differences and commonalities.
    J Hepatol. 2019 Jun 4. pii: S0168-8278(19)30297.
    PubMed     Text format    

  8. WILSON E, Covert E, Hoffmann J, Comstock E, et al
    A Pilot Study of Safety and Efficacy of HCV Retreatment with sofosbuvir/velpatasvir/voxilaprevir in Patients With or Without HIV (RESOLVE STUDY).
    J Hepatol. 2019 Jun 4. pii: S0168-8278(19)30307.
    PubMed     Text format     Abstract available


    J Infect Dis

  9. OLBRICH A, Wardemann H, Bohm S, Rother K, et al
    Repertoire and neutralizing activity of antibodies against E2 peptide in patients with spontaneous resolution of hepatitis C.
    J Infect Dis. 2019 Jun 4. pii: 5511345. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. HAN JW, Sung PS, Kim KH, Hong SH, et al
    Dynamic Changes in Ex Vivo T-Cell Function after Viral Clearance in Chronic HCV Infection.
    J Infect Dis. 2019 Jun 1. pii: 5510067. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Interferon Cytokine Res

  11. ABOUSHADY M, Alwassief A, Abdelrazik M, Ziada D, et al
    Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual Therapy.
    J Interferon Cytokine Res. 2019 Jun 6. doi: 10.1089/jir.2019.0041.
    PubMed     Text format     Abstract available

  12. O'BRIEN TR, Jackson SS
    What Have We Learned from Studies of IFN-lambda Variants and HCV Infection?
    J Interferon Cytokine Res. 2019 Jun 4. doi: 10.1089/jir.2019.0048.
    PubMed     Text format     Abstract available


    J Med Virol

  13. GRECO L, Renteria SCU, Guarneri D, Orlandi A, et al
    HEV and HAV seroprevalence in men that have sex with men (MSM): an update from Milan, Italy.
    J Med Virol. 2018 Feb 15. doi: 10.1002/jmv.25052.
    PubMed     Text format     Abstract available

  14. MARASCIO N, Pavia G, Romeo I, Talarico C, et al
    Real-life 3D therapy failure: Analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling.
    J Med Virol. 2018 Mar 25. doi: 10.1002/jmv.25073.
    PubMed     Text format     Abstract available


    J Virol

  15. KORNYEYEV D, Ramakrishnan D, Voitenleitner C, Livingston CM, et al
    Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes.
    J Virol. 2019 Jun 5. pii: JVI.00248-19. doi: 10.1128/JVI.00248.
    PubMed     Text format     Abstract available

  16. RAMAKRISHNAN D, Xing W, Beran RK, Chemuru S, et al
    Hepatitis B Virus X Protein Function Requires Zinc Binding.
    J Virol. 2019 Jun 5. pii: JVI.00250-19. doi: 10.1128/JVI.00250.
    PubMed     Text format     Abstract available


    PLoS One

  17. RODRIGUEZ-OSORIO I, Mena A, Meijide H, Morano L, et al
    Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals.
    PLoS One. 2019;14:e0217052.
    PubMed     Text format     Abstract available

  18. COFFIN PO, Santos GM, Behar E, Hern J, et al
    Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.
    PLoS One. 2019;14:e0217471.
    PubMed     Text format     Abstract available

  19. MEDIC S, Anastassopoulou C, Milosevic V, Dragnic N, et al
    Declining seroprevalence of hepatitis A in Vojvodina, Serbia.
    PLoS One. 2019;14:e0217176.
    PubMed     Text format     Abstract available

  20. ROBERTS H, Boktor SW, Waller K, Daar ZS, et al
    Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015.
    PLoS One. 2019;14:e0217455.
    PubMed     Text format     Abstract available

  21. GASTALDI G, Gomes D, Schneiter P, Montet X, et al
    Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients.
    PLoS One. 2019;14:e0217751.
    PubMed     Text format     Abstract available

  22. CHAILLON A, Mehta SR, Hoenigl M, Solomon SS, et al
    Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection.
    PLoS One. 2019;14:e0217964.
    PubMed     Text format     Abstract available

  23. WILHELM B, Waddell L, Greig J, Young I, et al
    Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries.
    PLoS One. 2019;14:e0216826.
    PubMed     Text format     Abstract available

  24. PRABDIAL-SING N, Makhathini L, Smit SB, Manamela MJ, et al
    Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.
    PLoS One. 2019;14:e0217415.
    PubMed     Text format     Abstract available


    Vaccine

  25. YU W, Lee LA, Liu Y, Scherpbier RW, et al
    Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31357.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: